Business Daily from THE HINDU group of publications
Tuesday, August 4, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

Update at 1300 hrs (IST)


Corporate
Venus Remedies gets product patent in South Africa

MUMBAI: Venus Remedies Ltd has informed BSE on Tuesday that it has added another product patent for TOBRACEF in its strong IPR basket.

The Companies and Intellectual Property Registration Office (CIPRO), South Africa, granted the patent of TOBRACEF which is indicated for the treatment of complicated mixed bacterial infection of Acute Pulmonary Exacerbations / Cystic Fibrosis / Chronic O bstructive Pulmonary disease.

The product is a novel fixed dose combination of cephalosporin and aminoglycoside.

Prev: Rupee strengthens
Next: Maruti expects exports to cross one lakh units

Business Line | NUS Index |

Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright copy; 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line